Brief: Genetron Health Releases New Data Results Of Hccscreen For Liver Cancer Early Screening In China
24/03/2021 21:05
March 24 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON HEALTH RELEASES NEW DATA RESULTS OF HCCSCREEN™
FOR
LIVER CANCER EARLY SCREENING IN CHINA
* GENETRON HOLDINGS LTD - CO PLANS TO INITIATE AN NMPA
REGISTRATIONAL TRIAL IN CHINA IN Q2 2021
* GENETRON HOLDINGS LTD - HCCSCREEN ACHIEVED 88% SENSITIVITY
AND
93% SPECIFICITY, COMPARED WITH 71% AND 95%, RESPECTIVELY, BY
ULTRASOUND PLUS AFP
* GENETRON HOLDINGS LTD - IN EARLY-STAGE PATIENTS,
SENSITIVITIES
OF HCCSCREENTM ARE 85%
Source text for Eikon: ID:nBwb25dM6a
Further company coverage: GTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private